Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Dana Morzaev"'
Autor:
Anastasia Godneva, Dmitry Kolobkov, Eran Segal, Michal Sela Rein, Maya Dadiani, Michal Bakalenik-Gavry, Dana Morzaev-Sulzbach, Yaeli Vachnish, maya Lotan-Pompan, Adina Weinberger, Einav Nili Gal-Yam
Publikováno v:
BMJ Open, Vol 12, Iss 11 (2022)
Introduction Breast cancer survivors treated with adjuvant endocrine therapy commonly experience weight gain, which has been associated with low adherence to therapy and worse breast cancer prognosis. We aim to assess whether a personalised postprand
Externí odkaz:
https://doaj.org/article/26ae86e912c24ad2a85ca055155c0986
Autor:
Tamir Baram, Nofar Erlichman, Maya Dadiani, Nora Balint-Lahat, Anya Pavlovski, Tsipi Meshel, Dana Morzaev-Sulzbach, Einav Nili Gal-Yam, Iris Barshack, Adit Ben-Baruch
Publikováno v:
Cells, Vol 10, Iss 6, p 1429 (2021)
Triple-negative breast cancer (TNBC) is primarily treated via chemotherapy; in parallel, efforts are made to introduce immunotherapies into TNBC treatment. CD4+ TNFR2+ lymphocytes were reported as Tregs that contribute to tumor progression. However,
Externí odkaz:
https://doaj.org/article/02e80236d79941b4a2f74fdefe89cd45
Autor:
Bella Kaufman, Eytan Domany, Iris Barshack, Raanan Berger, Einav Nili Gal-Yam, Ady Yosepovich, Smadar Kahana-Edwin, Dana Morzaev, Anya Pavlovski, Irina Marin, Nora Balint, Gili Perry, Shani Paluch-Shimon, Noa Bossel Ben-Moshe, Maya Dadiani
Supplementary methods Figure S1: The types of samples that were collected for each patient from cohort 2 (recurrence-freee patients). Figure S2: qPCR validations for Nanostring expression measurements. Figure S3: P1 miRNAs expression levels pre- and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2eb46de969e8c20a43641c380c6d429a
https://doi.org/10.1158/1078-0432.22457735
https://doi.org/10.1158/1078-0432.22457735
Autor:
Bella Kaufman, Eytan Domany, Iris Barshack, Raanan Berger, Einav Nili Gal-Yam, Ady Yosepovich, Smadar Kahana-Edwin, Dana Morzaev, Anya Pavlovski, Irina Marin, Nora Balint, Gili Perry, Shani Paluch-Shimon, Noa Bossel Ben-Moshe, Maya Dadiani
Purpose: Molecular evolution of tumors during progression, therapy, and metastasis is a major clinical challenge and the main reason for resistance to therapy. We hypothesized that microRNAs (miRNAs) that exhibit similar variation of expression throu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a39f14497681c052a8187d5d1f24f86
https://doi.org/10.1158/1078-0432.c.6523676.v1
https://doi.org/10.1158/1078-0432.c.6523676.v1
Autor:
Maya Dadiani, Gilgi Friedlander, Gili Perry, Nora Balint-Lahat, Shlomit Gilad, Dana Morzaev-Sulzbach, Anjana Shenoy, Noa Bossel Ben-Moshe, Anya Pavlovsky, Eytan Domany, Iris Barshack, Tamar Geiger, Bella Kaufman, Einav Nili Gal-Yam
Emerging evidence reinforce the role of non-genetic adaptive resistance to chemotherapy, that involves rewiring of transcriptional programs in surviving tumors. We combined longitudinal transcriptomics with temporal pattern analysis to dissect patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c18865b32c45878d677e042ac87d157a
https://doi.org/10.1101/2023.02.09.527790
https://doi.org/10.1101/2023.02.09.527790
Autor:
Einav Nili Gal-Yam, Miri Sklair-Levi, Yaeli Vachnish, Nora Balint-Lahat, Dana Morzaev-Sulzbach, Michal Bakalenik-Gavry, Renata Fearmann, Osnat Halshtok, Anat Shalmon, Michael Gotlieb, Yael Yagil, Keren Levanon, Rinat Bernstein-Molho, Amit Itay, Tali Shapira-Rotenberg, Opher Globus, Iris Barshack, Seth Salpeter, Vered Bar, Sara Aharon, Lubov Turovsky, Adi Zundelevich, Giuseppe Mallel, Hamutal Shahar, Hagit Shapira, Maya Dadiani
Publikováno v:
Cancer Research. 82:P1-08
Background. Neoadjuvant chemotherapy (NACT) is increasingly administered for high-risk breast cancer patients. Yet, oncologists lack an effective method for assessing response to treatment beyond clinicpathological features. Organ tissue slices fresh
Autor:
Einav Nili Gal-Yam, Liat Anafi, Irina Marin, Nino Oren, Adit Ben-Baruch, Dana Morzaev-Sulzbach, Stefan Wiemann, Bella Kaufman, Daniela Necula, Nora Balint-Lahat, Tamir Baram, Maya Dadiani, Smadar Kahana-Edwin, Camila Avivi, Anya Pavlovski, Iris Barshack, Cindy Körner
Publikováno v:
Cancer Immunology, Immunotherapy. 69:1315-1326
In view of the relatively limited efficacy of immunotherapies targeting the PD-1–PD-L1 axis in triple-negative breast cancer (TNBC) and of published reports on tumor-promoting roles of TNFR2+ tumor-infiltrating lymphocytes (TNFR2+ TILs), we determi
Autor:
Michal Sela Rein, Maya Dadiani, Anastasia Godneva, Michal Bakalenik-Gavry, Dana Morzaev-Sulzbach, Yaeli Vachnish, Dmitry Kolobkov, maya Lotan-Pompan, Adina Weinberger, Eran Segal, Einav Nili Gal-Yam
Publikováno v:
BMJ Open. 12:e062498
IntroductionBreast cancer survivors treated with adjuvant endocrine therapy commonly experience weight gain, which has been associated with low adherence to therapy and worse breast cancer prognosis. We aim to assess whether a personalised postprandi
Autor:
Anya Pavlovski, Iris Barshack, Tsipi Meshel, Adit Ben-Baruch, Maya Dadiani, Nora Balint-Lahat, Tamir Baram, Einav Nili Gal-Yam, Dana Morzaev-Sulzbach, Nofar Erlichman
Publikováno v:
Cells
Cells, Vol 10, Iss 1429, p 1429 (2021)
Volume 10
Issue 6
Cells, Vol 10, Iss 1429, p 1429 (2021)
Volume 10
Issue 6
Triple-negative breast cancer (TNBC) is primarily treated via chemotherapy
in parallel, efforts are made to introduce immunotherapies into TNBC treatment. CD4+ TNFR2+ lymphocytes were reported as Tregs that contribute to tumor progression. Howev
in parallel, efforts are made to introduce immunotherapies into TNBC treatment. CD4+ TNFR2+ lymphocytes were reported as Tregs that contribute to tumor progression. Howev
Autor:
Shalom Michowiz, Dana Morzaev, Nitza Goldenberg-Cohen, Tamar Azrad-Lebovitz, Neelan J. Marianayagam, Alon Zahavi, Moran Friedman, Myles Brookman, Edith Hochhauser, James D. Nicholson
Publikováno v:
Current eye research. 44(5)
Purpose To determine whether Toll-like receptor 4 knockout protects mice from corneal neovascularization following chemical injury compared to wild-type (WT) mice. Methods A chemical burn (75% silver nitrate, 25% potassium nitrate) was created under